Letter: assessment of histological disease activity in Crohn's disease clinical trials-a step in the right direction, but further optimisation needed
No Thumbnail Available
File version
Author(s)
Tsoi, Andrew H
Murugasu, Anand
Garg, Mayur
Murugasu, Anand
Garg, Mayur
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2021
Size
File type(s)
Location
License
Abstract
We read with interest the article by Almradi et al1 regarding consensus statements to standardise the assessment of histological disease activity in clinical trials of patients with Crohn's disease (CD).
Journal Title
Alimentary Pharmacology & Therapeutics
Conference Title
Book Title
Edition
Volume
54
Issue
4
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Clinical sciences
Pharmacology and pharmaceutical sciences
Persistent link to this record
Citation
Tsoi, AH; Murugasu, A; Garg, M, Letter: assessment of histological disease activity in Crohn's disease clinical trials-a step in the right direction, but further optimisation needed, Alimentary Pharmacology & Therapeutics, 2021, 54 (4), pp. 541-542